Pfizer sues online pharmacies

US patent infringement allegations


Pfizer has filed lawsuits against five online pharmacies for selling an unapproved copy of Pfizer's top-selling cholesterol medicine - Lipitor - the company says in a statement.

The suits were filed in US district courts in Delaware and Connecticut against Generic Lipitors, Online Rx DrugStore, WorldMedsRX, B. M. International, and Offshore Pharma.

Pfizer says the sites market a product called Storvas, which is advertised as being manufactured by Ranbaxy Pharmaceuticals Inc of India, a country that doesn't recognise drug patents.

The Pfizer lawsuits claim damages for infringement of Pfizer's patent and trademark rights for Lipitor. The complaints also seek to remove references to Lipitor in advertising materials and to eliminate computer links that misdirect patients to an illegal, unapproved product.

This is the first time a big pharmaceutical firm has tried to halt the sale of illegal generic medicines on the Net. Many dubious online pharmacies, companies which typically fail to provide a contact address or phone number, often sell 'generic variations' of medicines, in particular generic or herbal Viagra. The only FDA-approved brand, however, is Viagra produced by Pfizer, which owns the patent on its active ingredient.

The US Food and Drug Administration (FDA) gets dozens of reports of counterfeit drugs. They may look like the medicines the doctor would prescribe, but they often contain little or no active ingredients, or additional ingredients that could have serious side-effects.

Pfizer filed another suit on 12 April against Look4Generics.com in US District Court in Delaware. The company noted that the Internet provides easy access to websites that sell unapproved or counterfeit pharmaceutical products that could put patient health at risk. ®

Related stories

Big Pharma puts squeeze on Canadian Net pharmacies
E-pharmacies guilty of blatant disregard for health
Drugs agency calls for crackdown in e-pharmacies
Legality of online pharmacies questioned
Unscrupulous Net drugs trade led to death of student
e-Pharmacy sites offer risky prescription
Internet pharmacies draw fire on Capitol Hill


Other stories you might like

  • US won’t prosecute ‘good faith’ security researchers under CFAA
    Well, that clears things up? Maybe not.

    The US Justice Department has directed prosecutors not to charge "good-faith security researchers" with violating the Computer Fraud and Abuse Act (CFAA) if their reasons for hacking are ethical — things like bug hunting, responsible vulnerability disclosure, or above-board penetration testing.

    Good-faith, according to the policy [PDF], means using a computer "solely for purposes of good-faith testing, investigation, and/or correction of a security flaw or vulnerability."

    Additionally, this activity must be "carried out in a manner designed to avoid any harm to individuals or the public, and where the information derived from the activity is used primarily to promote the security or safety of the class of devices, machines, or online services to which the accessed computer belongs, or those who use such devices, machines, or online services."

    Continue reading
  • Intel plans immersion lab to chill its power-hungry chips
    AI chips are sucking down 600W+ and the solution could be to drown them.

    Intel this week unveiled a $700 million sustainability initiative to try innovative liquid and immersion cooling technologies to the datacenter.

    The project will see Intel construct a 200,000-square-foot "mega lab" approximately 20 miles west of Portland at its Hillsboro campus, where the chipmaker will qualify, test, and demo its expansive — and power hungry — datacenter portfolio using a variety of cooling tech.

    Alongside the lab, the x86 giant unveiled an open reference design for immersion cooling systems for its chips that is being developed by Intel Taiwan. The chip giant is hoping to bring other Taiwanese manufacturers into the fold and it'll then be rolled out globally.

    Continue reading
  • US recovers a record $15m from the 3ve ad-fraud crew
    Swiss banks cough up around half of the proceeds of crime

    The US government has recovered over $15 million in proceeds from the 3ve digital advertising fraud operation that cost businesses more than $29 million for ads that were never viewed.

    "This forfeiture is the largest international cybercrime recovery in the history of the Eastern District of New York," US Attorney Breon Peace said in a statement

    The action, Peace added, "sends a powerful message to those involved in cyber fraud that there are no boundaries to prosecuting these bad actors and locating their ill-gotten assets wherever they are in the world."

    Continue reading

Biting the hand that feeds IT © 1998–2022